A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared to the abdomen.
Epistemonikos ID: daf6f4b725b861149dd4a2cfc6a1ab473e690a42
First added on: Jul 02, 2025